ARTICLE
10 September 2024

CoA, September 5, 2024, Order On Application For Language Change, UPC_CoA_207/2024

BP
Bardehle Pagenberg

Contributor

BARDEHLE PAGENBERG combines the expertise of attorneys-at-law and patent attorneys. As one of the largest IP firms in Europe, BARDEHLE PAGENBERG advises in all fields of Intellectual Property, including all procedures before the patent and trademark offices as well as litigation before the courts through all instances.
The fact that the parties are domiciled in countries where the language of the proceedings chosen by the claimant is an official language is an important factor...
Germany Litigation, Mediation & Arbitration

1. Key takeaways

The fact that the parties are domiciled in countries where the language of the proceedings chosen by the claimant is an official language is an important factor in the decision on an application to use the language of the patent as the language of the proceedings.

An important factor is the fact that the claimant and two of the three defendants are domiciled in countries where German is an official language. MED-EL, Advanced Bionics AG and Advanced Bionics GmbH are domiciled in Austria, Switzerland and Germany respectively, while Advanced Bionics SARL has its domicile in France. Therefore, conducting the proceedings in German aligns with MED-EL's legitimate interests. Conversely, changing the language to English is not necessary to achieve a fair outcome for the defendants, as the official languages of their countries of domicile are German or French, not English.

Art. 49(5) UPCA does not require the application for a language change to be included in the Statement of defence. Against this background, R. 323.3 must be interpreted in such a manner that it does not preclude the lodging of the application before the Statement of defence.
Lodging the application before the Statement of defence is generally even more expedient, since it ensures that, if the application is successful, the language change can be implemented at an early stage of the proceedings.

2. Division

Luxembourg Court of Appeal

3. UPC number

UPC_CoA_207/2024

ORD_42779_2024

4. Type of proceedings

Appeal against an order rejecting an application to use the language of the patent as the language of the proceedings

5. Parties

APPELLANTS and Defendants in the main proceedings:

  1. ADVANCED BIONICS AG (Stäfa, Switzerland)
  2. ADVANCED BIONICS GMBH (Fellbach-Oeffingen, Germany)
  3. ADVANCED BIONICS SARL (Bron Cedex, France)

RESPONDENT and Claimant in the main proceedings:

MED-EL ELEKTROMEDIZINISCHE GERÄTE GESELLSCHAFT M.B.H. (Innsbruck, Austria)

6. Patent(s)

EP 4 074 373

7. Body of legislation / Rules

Rule 323 RoP, Art. 49(5) UPCA

To view the article click here

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More